Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 1997, for National Research Corporation (NRC Health). The company provides market research services, primarily renewable performance tracking and syndicated services. The financial statements are unaudited. Notably, the company operated as an S Corporation until October 13, 1997, and completed an Initial Public Offering (IPO) on October 16, 1997, transitioning to a C Corporation.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 1997 | Nine Months Ended Sep 30, 1997 |
|---|---|---|
| Total Revenues | $4,731,306 | $11,681,884 |
| Operating Income | $1,366,266 | $3,389,131 |
| Net Income | $1,421,267 | $3,541,162 |
| Pro Forma Net Income (40% tax rate) | $852,760 | $2,124,697 |
| Operating Margin | 28.8% | 29.0% |
| Cash and Equivalents (Sep 30, 1997) | $4,390,495 | |
| Working Capital (Sep 30, 1997) | $3,767,451 | |
| Net Cash from Operations (9 months) | $2,614,752 |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 30.0% for the quarter and 30.5% for the nine-month period compared to 1996. This was driven primarily by a 48.0% increase in renewable performance tracking services revenue due to new clients and expanded project scope.
- Expense Trends: Direct expenses increased 20.8% (quarter) and 25.5% (nine months), but decreased as a percentage of revenue (49.2% and 45.7% respectively) due to operational leverage. Selling, general, and administrative (SG&A) expenses rose 46.9% (quarter) and 41.9% (nine months), largely due to sales force expansion and software enhancements.
- Cash Flow: Net cash provided by operating activities decreased to $2.6 million for the nine months ended September 30, 1997, from $4.4 million in the prior year. This decline was attributed to the timing of receivable collections and growth in accounts receivable and unbilled revenues.
Outlook, Risks, and Unusual Items
- Subsequent Events (IPO): On October 16, 1997, the company completed an IPO selling 1,250,000 shares, generating net proceeds of approximately $16.9 million. These proceeds are not reflected in the September 30, 1997 balance sheet.
- Compensation Charges: In connection with the termination of S Corporation status, the company paid special cash bonuses of $1.7 million and an S Corporation distribution of $2.2 million. The $1.7 million bonus is expected to be recognized as a compensation charge in the fourth quarter of 1997.
- Tax Status Change: The company transitioned from S Corporation to C Corporation status on October 14, 1997. A deferred tax benefit of approximately $250,000 is expected to be recognized in the fourth quarter.
- Liquidity: While operating cash flow decreased, liquidity was significantly replenished by the IPO proceeds. The company maintains a strong working capital position of $3.8 million as of September 30, 1997.
Investor Verification Checklist
- Verify the impact of the $1.7 million special bonus charge on Q4 1997 earnings.
- Confirm the utilization of the $16.9 million IPO proceeds for working capital or acquisitions as stated in management commentary.
- Monitor the collection of the $2.1 million in trade accounts receivable and $456,000 in unbilled revenues to ensure cash conversion aligns with projections.
- Review the pro forma tax implications now that the company is a C Corporation, as historical net income figures do not reflect federal/state income taxes.
- Assess the sustainability of the 29% operating margin given the 46.9% increase in SG&A expenses driven by sales force expansion.